Sigpride MP 1mg/500mg/15mg Tablet SR
Marketer
Sigmus Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sigpride MP 1mg/500mg/15mg Tablet SR
Diabex Trio 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. Used alongside diet and exercise, this treatment improves blood sugar control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen. Take with food to prevent stomach discomfort. If a dose is missed, take it promptly unless your next dose is imminent; then skip the missed dose. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood sugar monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your physician of any kidney, liver, or heart conditions before commencing treatment. Pregnant or lactating individuals should consult their doctor. Kidney function will be assessed before treatment begins. Limit alcohol consumption as it may heighten side effect risk.
Primary Ingredients of Sigpride MP 1mg/500mg/15mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Sigpride MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sigpride MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sigpride MP 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Sigpride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sigpride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Sigpride MP 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Sigpride MP 1mg/500mg/15mg Tablet SR works:
Sigpride MP 1mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act via separate pathways to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Sigpride MP 1mg/500mg/15mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Sigpride MP 1mg/500mg/15mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sigpride MP tablet (1mg/500mg/15mg) is likely unsuitable for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Sigpride MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated for individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Sigpride MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. Sigpride MP 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sigpride MP 1mg/500mg/15mg Tablet SR :
Should you forget to take a Sigpride MP 1mg/500mg/15mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Sigpride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently